Immuno-Monitoring
ImmunAlp PDF Print E-mail

IMMUNALP_FINAL_blue
Overview

The process of identifying compounds with toxic properties in the early stages of drug development is an essential step in avoiding wasting valuable time and money on unsuitable and usafe drug candidates.
Read more...
 


TECHNOLOGY FOCUS

TESTIMONIALS

« When we identified Professor Drouet's technology at the UJF it was immediately apparent that this invention met all our needs." T Paper - Biosynex
Read more...